Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies

Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM) are increasing rapidly worldwide, reaching epidemic proportions. Their association, based on common metabolic risk factors (obesity, insulin resistance (IR), unhealthy lifestyle), brings an additional risk of...

Full description

Bibliographic Details
Main Authors:	Cosmina-Theodora Diaconu, Cristian Guja
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Journal of Clinical Medicine
Subjects:	Nonalcoholic Fatty Liver Disease (NAFLD) Type 2 Diabetes Mellitus (T2DM) Metabolic Syndrome-Associated Fatty Liver Disease (MAFLD) treatment
Online Access:	https://www.mdpi.com/2077-0383/11/17/5144

Similar Items

Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
by: Alessandro Mantovani, et al.
Published: (2022-10-01)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
by: Giovanni Targher
Published: (2020-10-01)

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
by: Mohamed AA, et al.
Published: (2022-06-01)

Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
by: Tamara Bassal, et al.
Published: (2022-11-01)

The Triangle of Nonalcoholic Fatty Liver Disease, Metabolic Dysfunction, and Periodontitis: Analysis of the Dental, Oral, Medical and Epidemiological (DOME) Records-Based Nationwide Research
by: Doron Ram, et al.
Published: (2022-12-01)

Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease
by: Mohamed Zaiou, et al.
Published: (2021-09-01)

Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
by: Daniela Maria Tanase, et al.
Published: (2020-08-01)

Nonalcoholic fatty liver disease (NAFLD) among older adults
by: Panyavee Pitisuttithum, et al.
Published: (2022-12-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
by: Sara Volpe, et al.
Published: (2022-11-01)

Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease
by: Sun T, et al.
Published: (2023-02-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
by: Khamis Al Hashmi, et al.
Published: (2024-03-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions
by: Ayokanmi Ore, et al.
Published: (2021-08-01)

Association of subclinical hypothyroidism with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A cross-sectional study
by: Vahid Sheikhi, et al.
Published: (2022-01-01)

Risk factors in nonalcoholic fatty liver disease
by: Eunji Ko, et al.
Published: (2023-02-01)

Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target
by: Chun-Liang Chen, et al.
Published: (2022-09-01)

Metabolic Syndrome and Nonalcoholic Fatty Liver Disease: Nutritional Approach for Prevention
by: Zamzam Paknahad, et al.
Published: (2013-11-01)

Determination of Frequency of Diabetes and Pre-Diabetes in Patients with Nonalcoholic Fatty Liver Disease and Comparison with a Control Group
by: Bahram Pakzad, et al.
Published: (2016-03-01)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
by: Alessandro Mantovani, et al.
Published: (2020-12-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
by: Anna Jeznach-Steinhagen, et al.
Published: (2019-05-01)

TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD
by: Imke Liebold, et al.
Published: (2023-01-01)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
by: Jin Feng, et al.
Published: (2021-12-01)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
by: Fan Y, et al.
Published: (2021-07-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
by: Marta Flisiak-Jackiewicz, et al.
Published: (2021-03-01)

Nitrate containing vegetables and dietary nitrate and nonalcoholic fatty liver disease: a case control study
by: Parvin Mirmiran, et al.
Published: (2023-01-01)

Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
by: Mohammad Habibullah, et al.
Published: (2024-01-01)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
by: Ioanna Aggeletopoulou, et al.
Published: (2023-08-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

Corrigendum: The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
by: Congwei Gu, et al.
Published: (2022-07-01)

Non-invasive evaluation of liver stiffness in nonalcoholic fatty liver disease: supersonic shear imaging, FibroScan or ARFI?
by: Coskun Ozturker, et al.
Published: (2016-12-01)

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: Marcin Kosmalski, et al.
Published: (2022-03-01)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
by: Ekaterina E. Mishina, et al.
Published: (2017-12-01)

Global incidence and prevalence of nonalcoholic fatty liver disease
by: Margaret LP Teng, et al.
Published: (2023-02-01)

Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study
by: Yusuke Johira, et al.
Published: (2023-06-01)

Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Ling Pan, et al.
Published: (2023-05-01)